- Home
- ORC vs PHAR Comparison
ORC vs PHAR Comparison
Compare ORC & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORC
- PHAR
- Stock Information
- Founded
- ORC 2010
- PHAR 1988
- Country
- ORC United States
- PHAR Netherlands
- Employees
- ORC N/A
- PHAR N/A
- Industry
- ORC Real Estate Investment Trusts
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- ORC Real Estate
- PHAR Health Care
- Exchange
- ORC Nasdaq
- PHAR Nasdaq
- Market Cap
- ORC 623.6M
- PHAR 618.3M
- IPO Year
- ORC 2013
- PHAR N/A
- Fundamental
- Price
- ORC $8.30
- PHAR $8.74
- Analyst Decision
- ORC Buy
- PHAR Strong Buy
- Analyst Count
- ORC 3
- PHAR 3
- Target Price
- ORC $9.50
- PHAR $27.00
- AVG Volume (30 Days)
- ORC 3.0M
- PHAR 5.6K
- Earning Date
- ORC 01-30-2025
- PHAR 03-13-2025
- Dividend Yield
- ORC 17.43%
- PHAR N/A
- EPS Growth
- ORC N/A
- PHAR N/A
- EPS
- ORC 0.58
- PHAR N/A
- Revenue
- ORC $54,406,000.00
- PHAR $285,745,000.00
- Revenue This Year
- ORC N/A
- PHAR $20.08
- Revenue Next Year
- ORC N/A
- PHAR $9.22
- P/E Ratio
- ORC $14.41
- PHAR N/A
- Revenue Growth
- ORC N/A
- PHAR 30.64
- 52 Week Low
- ORC $7.41
- PHAR $6.65
- 52 Week High
- ORC $9.08
- PHAR $13.20
- Technical
- Relative Strength Index (RSI)
- ORC 62.14
- PHAR 40.05
- Support Level
- ORC $7.88
- PHAR $7.95
- Resistance Level
- ORC $8.38
- PHAR $9.35
- Average True Range (ATR)
- ORC 0.18
- PHAR 0.52
- MACD
- ORC 0.04
- PHAR -0.16
- Stochastic Oscillator
- ORC 81.51
- PHAR 22.76
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc invests in residential mortgage-backed securities (RMBS) across the United States. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.